Sinyoung Jeong Selected Research

CA-125 Antigen (CA 125 Antigen)

2/2022

Application of a novel microscopic technique for quantifying CA125 binding to circulating mononuclear cells in longitudinal specimens during treatment for ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sinyoung Jeong Research Topics

Disease

2	Ovarian Neoplasms (Ovarian Cancer) 04/2021 - 01/2020
2	Acne Vulgaris 01/2020 - 07/2018
2	Neoplasms (Cancer) 01/2017 - 03/2015
2	Lung Neoplasms (Lung Cancer) 07/2015 - 03/2015
1	Ovarian Epithelial Carcinoma 02/2022
1	Central Nervous System Diseases (CNS Diseases) 11/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2021
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Dehydration (Water Stress) 12/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Breast Neoplasms (Breast Cancer) 03/2015

Drug/Important Bio-Agent (IBA)

3	ErbB Receptors (EGF Receptor)IBA 02/2021 - 03/2015
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 04/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 07/2018
2	Minocycline (Cyclops)FDA LinkGeneric 01/2020 - 07/2018
1	CA-125 Antigen (CA 125 Antigen)IBA 02/2022
1	SialomucinsIBA 04/2021
1	Prostate-Specific Antigen (Semenogelase)IBA 02/2021
1	Tumor Biomarkers (Tumor Markers)IBA 02/2021
1	GoldIBA 01/2020
1	tazarotene (Tazorac)FDA Link 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	A 17 (A-17)IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	RetinoidsIBA 01/2020
1	Hygroscopic AgentsIBA 12/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Biocompatible Materials (Biomaterials)IBA 07/2015
1	human ERBB2 proteinIBA 03/2015
1	Antineoplastic Agents (Antineoplastics)IBA 03/2015
1	AntibodiesIBA 03/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2015

Therapy/Procedure

2	Photothermal Therapy 07/2015 - 03/2015
1	Fluid Therapy (Oral Rehydration Therapy) 12/2018
1	Oral Administration 07/2018
1	Optical Fibers 03/2015
1	Lasers (Laser) 03/2015